# FDA recall D-1862-2019

> **Torrent Pharma Inc.** · Class II · drug recall initiated 2019-09-06.

## Product

Anagrelide Capsules, USP, 0.5 mg, 100-count bottle, Rx only,  Manufactured in India for: Torrent Pharma Inc., Basking Ridge, NJ 07920, NDC 13668-453-01.

## Reason for recall

Failed Impurities/Degradation Specifications: High Out Of Specification results for impurities detected during routine stability testing.

## Distribution

Nationwide in the USA and Puerto Rico

## Key facts

- **Recall number:** D-1862-2019
- **Recalling firm:** Torrent Pharma Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2019-09-06
- **Report date:** 2019-09-25
- **Termination date:** 2020-11-03

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Basking Ridge, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1862-2019

## Citation

> AI Analytics. FDA recall D-1862-2019. Retrieved 2026-06-26 from https://api.ai-analytics.org/recall/D-1862-2019. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*